Relation Between Serum IGF-1 & BMI In Acne Vulgaris

Recruiting

• Conditions: Evaluation of Serum Level of Insulin Like Growth Factor 1

• Registration Number: NCT05301569
• Lead Sponsor: Assiut University

Brief Summary

cross-sectional study in which participants will be recruited at dermatology \& Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists \& obtaining an informed consent

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-03-16
• Study First Submitted QC: 2022-03-26
• Study First Posted: 2022-03-29
• Study Start: 2023-04-01
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-03
• Last Update Posted: 2023-12-05
• Primary Completion: 2024-05-30
• Study Completion: 2024-05-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1. Patients aged from 15 to 45 years old suffering from acne vulgaris.
2. Both sexes.

Exclusion Criteria

1. Insulin resistance and diabetic patients
2. Females with polycystic ovarian syndrome
3. Treatment with drugs that can influence IGF-1level such as corticosteroid, insulin, hypoglycemic agents, and isotretinoin within one year before the date of study.
4. Other causes of acne or acneform eruption as steroid-induced

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of serum level of insulin like growth factor 1 in acne vulgaris	1 year	using the Chemiluminescent Microparticle Immunoassay

Trial Locations

Locations (1)

Rania Sallam; 🇪🇬 Cairo, Qalubya, Egypt